%D9%81%D8%B1%D8%B7_%D8%B6%D8%BA%D8%B7_%D8%A7%D9%84%D8%AF%D9%85_%D8%A7%D9%84%D8%A8%D8%A7%D8%A8%D9%8A%E0%A6%AA%E0%A7%8B%E0%A6%B0%E0%A7%8D%E0%A6%9F%E0%A6%BE%E0%A6%B2_%E0%A6%B9%E0%A6%BE%E0%A6%87%E0%A6%AA%E0%A6%BE%E0%A6%B0%E0%A6%9F%E0%A7%87%E0%A6%A8%E0%A6%B6%E0%A6%A8Hipertensi%C3%B3_portalCategory:Portal_hypertensionPort%C3%A1ln%C3%AD_hypertenzePortale_HypertensionPortal_hypertensionHipertensi%C3%B3n_portal%D9%BE%D8%B1%D9%81%D8%B4%D8%A7%D8%B1%DB%8C_%D9%88%D8%B1%DB%8C%D8%AF_%D8%A8%D8%A7%D8%A8Hypertension_portaleHipertensi%C3%B3n_portalIpertensione_portale%E9%96%80%E8%84%88%E5%9C%A7%E4%BA%A2%E9%80%B2%E7%97%87Portale_hypertensieNadci%C5%9Bnienie_wrotneHipertens%C3%A3o_portal%D0%9F%D0%BE%D1%80%D1%82%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0%D1%8F_%D0%B3%D0%B8%D0%BF%D0%B5%D1%80%D1%82%D0%B5%D0%BD%D0%B7%D0%B8%D1%8F%D0%9F%D0%BE%D1%80%D1%82%D0%B0%D0%BB%D0%BD%D0%B0_%D1%85%D0%B8%D0%BF%D0%B5%D1%80%D1%82%D0%B5%D0%BD%D0%B7%D0%B8%D1%98%D0%B0Portahypertension%E0%AE%88%E0%AE%B0%E0%AE%B2%E0%AF%8D_%E0%AE%B5%E0%AE%BE%E0%AE%AF%E0%AE%BF%E0%AE%A9%E0%AE%BE%E0%AE%B3_%E0%AE%AE%E0%AE%BF%E0%AE%95%E0%AF%88%E0%AE%AF%E0%AE%B4%E0%AF%81%E0%AE%A4%E0%AF%8D%E0%AE%A4%E0%AE%AE%E0%AF%8D%D0%9F%D0%BE%D1%80%D1%82%D0%B0%D0%BB%D1%8C%D0%BD%D0%B0_%D0%B3%D1%96%D0%BF%D0%B5%D1%80%D1%82%D0%B5%D0%BD%D0%B7%D1%96%D1%8FT%C4%83ng_%C3%A1p_l%E1%BB%B1c_t%C4%A9nh_m%E1%BA%A1ch_c%E1%BB%ADaQ124604%E9%96%80%E8%84%88%E9%AB%98%E5%A3%93
about
P828
Laparoscopic Splenectomy and Azygoportal Disconnection: a Systematic ReviewTherapeutic potential of microRNA: a new target to treat intrahepatic portal hypertension?The accuracy of ultrasonography for the evaluation of portal hypertension in patients with cirrhosis: a systematic reviewLow-dose splenic irradiation in symptomatic congestive splenomegaly: report of five cases with literature dataTherapeutic approaches for portal biliopathy: A systematic reviewHepatic encephalopathy.Non-invasive diagnostic and prognostic evaluation of liver cirrhosis and portal hypertension.Effect of PAH specific therapy on pulmonary hemodynamics and six-minute walk distance in portopulmonary hypertension: a systematic review and meta-analysis.Erosive gastritis and portal hypertension.Sinistral portal hypertension.Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis.Hepatic hydrothorax: clinical features, management, and outcomes in 77 patients and review of the literature.Transient elastography versus hepatic venous pressure gradient for diagnosing portal hypertension: a systematic review and meta-analysis.Inflammation: a way to understanding the evolution of portal hypertension.The mast cell integrates the splanchnic and systemic inflammatory response in portal hypertension.The current role of decompressive shunts and liver transplant in portal hypertension.Management of portal hypertensive gastropathy and other bleeding.Case report and systematic literature review of a novel etiology of sinistral portal hypertension presenting with UGI bleeding: Left gastric artery pseudoaneurysm compressing the splenic vein treated by embolization of the pseudoaneurysm.The kidney in cirrhosis with portal hypertension.Carvedilol in the treatment of portal hypertension.Hemodynamic alterations in cirrhosis and portal hypertension.Classification of cirrhosis: the clinical use of HVPG measurements.Prognostic markers in patients with ascites and hepatorenal syndrome.Prognostic markers in patients with cirrhosis and portal hypertension who have not bled.Prognostic evaluation of patients with acute variceal bleedingPrognostic markers in patients who have recovered from an acute variceal bleeding: role of HVPG measurement.Prognostic assessment in patients with hepatic encephalopathy.The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension.Idiopathic non-cirrhotic portal hypertension: a review.Ultrasonography for Noninvasive Assessment of Portal Hypertension.Portal hypertension: Imaging of portosystemic collateral pathways and associated image-guided therapy.Austrian consensus guidelines on the management and treatment of portal hypertension (Billroth III).Current management of refractory ascites in patients with cirrhosis.Role of the renin-angiotensin system in hepatic fibrosis and portal hypertension.Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectivesElastography-based screening for esophageal varices in patients with advanced chronic liver disease
P921
description
Krankheit
@de
Zirkulazio-sistema portaleko z ...... eko tronbosiak eragin dezakete
@eu
aumento delle resistenze al flusso ematico della vena porta
@it
hypertension in the hepatic portal system
@en
portal hypertansion
@hi
مَرَضٌ بَشَرِيٌّ
@ar
name
Hipertensión portal
@gl
Nadciśnienie wrotne
@pl
Tăng áp lực tĩnh mạch cửa
@vi
gorbwysedd porthol
@cy
hipertensió portal
@ca
hipertensión portal
@es
hipertensão portal
@pt
hypertension portale
@fr
ipertensione portale
@it
portahypertension
@sv
type
label
Hipertensión portal
@gl
Nadciśnienie wrotne
@pl
Tăng áp lực tĩnh mạch cửa
@vi
gorbwysedd porthol
@cy
hipertensió portal
@ca
hipertensión portal
@es
hipertensão portal
@pt
hypertension portale
@fr
ipertensione portale
@it
portahypertension
@sv
altLabel
hipertension portal
@es
porta-hipertentsio
@eu
門靜脈高壓症
@zh-hant
门静脉高压症
@zh-cn
prefLabel
Hipertensión portal
@gl
Nadciśnienie wrotne
@pl
Tăng áp lực tĩnh mạch cửa
@vi
gorbwysedd porthol
@cy
hipertensió portal
@ca
hipertensión portal
@es
hipertensão portal
@pt
hypertension portale
@fr
ipertensione portale
@it
portahypertension
@sv
P2888
P780
P828
P227
P349
P486
P508
P6366
P646
P672
P1417
science/portal-hypertension